Genu Sinistra Tuberculosis Arthritis with Drug-Induced Liver Injury Caused by Anti-Tuberculosis Drugs in Patients Confirmed with COVID-19
DOI:
https://doi.org/10.37275/bsm.v6i3.461Keywords:
Anti-tuberculosis drugs, Arthritis tuberculosis, COVID-19, Drug-induced liver injury, Drugs desensitizationAbstract
Background: Tuberculous arthritis is a form of extrapulmonary tuberculosis and has a significant effect on patient morbidity and mortality. This case report aims to describe clinical signs and symptoms, results of laboratory tests, radiology, and outcome of tuberculosis arthritis cases.
Case presentation: A 36-year-old woman came to the emergency room with the main complaint of pain, swelling, and warmth when palpating the knee for the past week. The pain felt worse during activities such as walking. The patient also complains of fever, loss of appetite, and unwanted weight loss. Physical examination showed sharp pain and swelling in the knee, limited range of movement (ROM), and a positive balloon sign, while laboratory tests showed increased leukocytes, neutrophils, and C-reactive protein. After the diagnosis of genu tuberculosis arthritis was established, the administration of anti-tuberculosis drugs (OAT) was started. After one week, the patient complained of pain in the left knee and progressive nausea. Liver function tests showed an increase in SGOT and SGPT. The patient then started OAT desensitization. A month later, the patient underwent an open synovectomy with liquefaction necrosis. Although the first desensitization of tuberculosis still causes drug-induced liver injury, the second desensitization involves gradually increasing doses of rifampicin accompanied by close monitoring of liver tests.
Conclusion: Early administration of anti-tuberculosis drugs in tuberculosis arthritis can improve healing, maintain joint function, and prevent further damage. Anti-tuberculosis drug desensitization is the primary management of drug-induced liver injury.
Authors
- Yonis Ismed1*
- Radiyati Umi Partan2
- 1Specialized Residency Training, Department of Internal Medicine, Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
- 2Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
Corresponding author Yonis Ismed — yonisismed@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
As our aim is to disseminate original research article, hence the publishing right is a necessary one. The publishing right is needed in order to reach the agreement between the author and publisher. As the journal is fully open access, the authors will sign an exclusive license agreement.
The authors have the right to:
- Share their article in the same ways permitted to third parties under the relevant user license.
- Retain copyright, patent, trademark and other intellectual property rights including research data.
- Proper attribution and credit for the published work.
For the open access article, the publisher is granted to the following right.
- The non-exclusive right to publish the article and grant right to others.
- For the published article, the publisher applied for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
